glp-1 news oct 21 2025 What's next for innovation: A primer on the race reshaping pharma and chronic disease care Regulating a "Miracle Drug": GLP-1
Description
Read More
The glycemic index (GI) is a helpful tool for understanding how different foods impact blood sugar
GLP-1 agonists like semaglutide and tirzepatide are groundbreaking for weight loss
But a new large study suggests they both raise and lower the risk, with the lower risk from alcohol reduction:
Be sure to look for our new labels with the MADE IN USA SHIELD
From a pharma strategy perspective, this is a prudent and timely regulatory signal
